Axi-cel in CNS Lymphoma

NCT04608487 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Lymphoma Cns

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Axicabtagene Ciloleucel

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]